(Q38582200)

4 September 2017

title

Neurons and T cells: Understanding this interaction for inflammatory neurological diseases (English)

1 reference

4 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26345279%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Raphaël Bernard-Valnet

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26345279%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Roland Liblau

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26345279%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Christina Gebauer

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26345279%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

language of work or name

English

0 references

publication date

8 September 2015

1 reference

European Journal of Immunology

4 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26345279%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26345279%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26345279%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

2712-2720

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26345279%20AND%20SRC:MED&resulttype=core&format=json

What is the blood-brain barrier (not)?

1 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Elevated neuronal expression of CD200 protects Wlds mice from inflammation-mediated neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

The anatomical and cellular basis of immune surveillance in the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Structural and functional features of central nervous system lymphatic vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Neurons as targets for T cells in the nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Innate and adaptive immune responses in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Pathological mechanisms in progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

H2-K(b) and H2-D(b) regulate cerebellar long-term depression and limit motor learning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

MHC class I molecules are present both pre- and postsynaptically in the visual cortex during postnatal development and in adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Neuronal cells are deficient in loading peptides onto MHC class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Neurons are MHC class I-dependent targets for CD8 T cells upon neurotropic viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Capture, crawl, cross: the T cell code to breach the blood-brain barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

CD8+ T cells primed in the periphery provide time-bound immune-surveillance to the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Central nervous system recruitment of effector memory CD8+ T lymphocytes during neuroinflammation is dependent on α4 integrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Cutting edge: loss of α4 integrin expression differentially affects the homing of Th1 and Th17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Th17 lymphocytes traffic to the central nervous system independently of α4 integrin expression during EAE

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Integrin alpha L controls the homing of regulatory T cells during CNS autoimmunity in the absence of integrin alpha 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Therapeutic use of CCR5 antagonists is supported by strong expression of CCR5 on CD8+ T cells in progressive multifocal leukoencephalopathy-associated immune reconstitution inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Maraviroc and JC virus-associated immune reconstitution inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

CCR5 deficiency increases risk of symptomatic West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Role of neurotrophins in the development and function of neural circuits that regulate energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

MHCII-independent CD4+ T cells protect injured CNS neurons via IL-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

CNS repair requires both effector and regulatory T cells with distinct temporal and spatial profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Immunization with a Myelin-Derived Antigen Activates the Brain's Choroid Plexus for Recruitment of Immunoregulatory Cells to the CNS and Attenuates Disease Progression in a Mouse Model of ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Astrocyte-derived TGF-β1 accelerates disease progression in ALS mice by interfering with the neuroprotective functions of microglia and T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Local CD4 and CD8 T-cell reactivity to HSV-1 antigens documents broad viral protein expression and immune competence in latently infected human trigeminal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Role of CD8+ T cells in control of West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Fas Ligand Interactions Contribute to CD8+ T-Cell-Mediated Control of West Nile Virus Infection in the Central Nervous System

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

CD8+ T cells use TRAIL to restrict West Nile virus pathogenesis by controlling infection in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

CXCR3 mediates region-specific antiviral T cell trafficking within the central nervous system during West Nile virus encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Neuroprotective intervention by interferon-γ blockade prevents CD8+ T cell-mediated dendrite and synapse loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Interferon-gamma directly induces neurotoxicity through a neuron specific, calcium-permeable complex of IFN-gamma receptor and AMPA GluR1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Conflicting consequences of immunity to cancer versus autoimmunity to neurons: insights from paraneoplastic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

T cells targeting a neuronal paraneoplastic antigen mediate tumor rejection and trigger CNS autoimmunity with humoral activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Tumor-specific killer cells in paraneoplastic cerebellar degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

The initiation and prevention of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

From classic to spontaneous and humanized models of multiple sclerosis: impact on understanding pathogenesis and drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Inflammatory cortical demyelination in early multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

IL-17 and glutamate excitotoxicity in the pathogenesis of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

In vivo imaging of partially reversible th17 cell-induced neuronal dysfunction in the course of encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Role of CD8 T cell subsets in the pathogenesis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Paraneoplastic syndromes of the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Paraneoplastic CDR2 and CDR2L antibodies affect Purkinje cell calcium homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

CD8 positive T-cell infiltration in the dentate nucleus of paraneoplastic cerebellar degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

What is microglia neurotoxicity (Not)?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Long term lymphocyte reconstitution after alemtuzumab treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Differential reconstitution of T cell subsets following immunodepleting treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Daclizumab (anti-CD25) in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Exacerbations of multiple sclerosis in patients treated with gamma interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Adult-onset immunodeficiency in Thailand and Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Aptamers as therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

A new nucleic acid-based agent inhibits cytotoxic T lymphocyte-mediated immune disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Mechanisms of central and peripheral T-cell tolerance: lessons from experimental models of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Harnessing nanoparticles for immune modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Axonal Loss and Neurofilament Phosphorylation Changes Accompany Lesion Development and Clinical Progression in Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

Studies on the problem of corneal homografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

7 January 2021

Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

7 January 2021

Neuronal FasL induces cell death of encephalitogenic T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

7 January 2021

FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

7 January 2021

Essential role of CD8+CD122+ regulatory T cells in the recovery from experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

7 January 2021

RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

7 January 2021

Pervasive axonal transport deficits in multiple sclerosis models

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201545759

7 January 2021